These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 2506333)
1. Suicide inactivation of cytochrome P-450 by methoxsalen. Evidence for the covalent binding of a reactive intermediate to the protein moiety. Labbe G; Descatoire V; Beaune P; Letteron P; Larrey D; Pessayre D J Pharmacol Exp Ther; 1989 Sep; 250(3):1034-42. PubMed ID: 2506333 [TBL] [Abstract][Full Text] [Related]
2. Bioactivation of 8-methoxypsoralen and irreversible inactivation of cytochrome P-450 in mouse liver microsomes: modification by monoclonal antibodies, inhibition of drug metabolism and distribution of covalent adducts. Mays DC; Hilliard JB; Wong DD; Chambers MA; Park SS; Gelboin HV; Gerber N J Pharmacol Exp Ther; 1990 Aug; 254(2):720-31. PubMed ID: 2117068 [TBL] [Abstract][Full Text] [Related]
3. Selective inhibitory interactions of alkoxymethylenedioxybenzenes towards mono-oxygenase activity in rat-hepatic microsomes. Murray M; Hetnarski K; Wilkinson CF Xenobiotica; 1985 May; 15(5):369-79. PubMed ID: 4036165 [TBL] [Abstract][Full Text] [Related]
4. Immunochemical detection and quantitation of microsomal cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate:cytochrome P-450 reductase in the rat ventral prostate. Haaparanta T; Halpert J; Glaumann H; Gustafsson JA Cancer Res; 1983 Nov; 43(11):5131-7. PubMed ID: 6413054 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of oxidative drug metabolism by orphenadrine: in vitro and in vivo evidence for isozyme-specific complexation of cytochrome P-450 and inhibition kinetics. Reidy GF; Mehta I; Murray M Mol Pharmacol; 1989 May; 35(5):736-43. PubMed ID: 2725477 [TBL] [Abstract][Full Text] [Related]
6. Imipramine-induced inactivation of a cytochrome P450 2D enzyme in rat liver microsomes: in relation to covalent binding of its reactive intermediate. Masubuchi Y; Igarashi S; Suzuki T; Horie T; Narimatsu S J Pharmacol Exp Ther; 1996 Nov; 279(2):724-31. PubMed ID: 8930177 [TBL] [Abstract][Full Text] [Related]
7. Changes in the concentration of seven forms of cytochrome P-450 in primary cultures of adult rat hepatocytes. Steward AR; Dannan GA; Guzelian PS; Guengerich FP Mol Pharmacol; 1985 Jan; 27(1):125-32. PubMed ID: 3965924 [TBL] [Abstract][Full Text] [Related]
8. Inactivation of cytochrome P-450 by the drug methoxsalen. Fouin-Fortunet H; Tinel M; Descatoire V; Letteron P; Larrey D; Geneve J; Pessayre D J Pharmacol Exp Ther; 1986 Jan; 236(1):237-47. PubMed ID: 3941395 [TBL] [Abstract][Full Text] [Related]
9. Biotransformation of N,N',N''-triethylenethiophosphoramide: oxidative desulfuration to yield N,N',N''-triethylenephosphoramide associated with suicide inactivation of a phenobarbital-inducible hepatic P-450 monooxygenase. Ng SF; Waxman DJ Cancer Res; 1990 Feb; 50(3):464-71. PubMed ID: 2105156 [TBL] [Abstract][Full Text] [Related]
10. In vitro formation of an inhibitory complex between an isosafrole metabolite and rat hepatic cytochrome P-450 PB-B. Murray M; Reidy GF Drug Metab Dispos; 1989; 17(4):449-54. PubMed ID: 2571488 [TBL] [Abstract][Full Text] [Related]
11. Major isozymes of rat liver microsomal cytochrome P-450 involved in the N-oxidation of N-isopropyl-alpha-(2-methylazo)-p-toluamide, the azo derivative of procarbazine. Prough RA; Brown MI; Dannan GA; Guengerich FP Cancer Res; 1984 Feb; 44(2):543-8. PubMed ID: 6692359 [TBL] [Abstract][Full Text] [Related]
12. Mechanism-based inactivation of the major beta-naphthoflavone-inducible isozyme of rat liver cytochrome P-450 by the chloramphenicol analog N-(2-p-nitrophenethyl)dichloroacetamide. Miller NE; Halpert JR Drug Metab Dispos; 1987; 15(6):846-51. PubMed ID: 2893712 [TBL] [Abstract][Full Text] [Related]
13. Interaction of constitutive and phenobarbital-induced cytochrome P-450 isozymes during the sequential oxidation of benzphetamine. Explanation for the difference in benzphetamine-induced hydrogen peroxide production and 455-nm complex formation in microsomes from untreated and phenobarbital-treated rats. Jeffery EH; Mannering GJ Mol Pharmacol; 1983 May; 23(3):748-57. PubMed ID: 6865917 [TBL] [Abstract][Full Text] [Related]
14. Triphenyltin acetate-mediated in vitro inactivation of rat liver cytochrome P-450. Nebbia C; Ceppa L; Dacasto M; Carletti M J Toxicol Environ Health A; 1999 Mar; 56(6):433-47. PubMed ID: 10096365 [TBL] [Abstract][Full Text] [Related]
15. Microsomal oxidation of N,N-diethylformamide and its effect on P450-dependent monooxygenases in rat liver. Amato G; Longo V; Mazzaccaro A; Gervasi PG Chem Res Toxicol; 1996; 9(5):882-90. PubMed ID: 8828925 [TBL] [Abstract][Full Text] [Related]
16. Selective inactivation by chloramphenicol of the major phenobarbital-inducible isozyme of dog liver cytochrome P-450. Ciaccio PJ; Duignan DB; Halpert JR Drug Metab Dispos; 1987; 15(6):852-6. PubMed ID: 2893713 [TBL] [Abstract][Full Text] [Related]
17. Differences in cytochrome P450-mediated biotransformation of 1,2-dichlorobenzene by rat and man: implications for human risk assessment. Hissink AM; Oudshoorn MJ; Van Ommen B; Haenen GR; Van Bladeren PJ Chem Res Toxicol; 1996 Dec; 9(8):1249-56. PubMed ID: 8951226 [TBL] [Abstract][Full Text] [Related]
18. Metabolic activation of the nitroaromatic antiandrogen flutamide by rat and human cytochromes P-450, including forms belonging to the 3A and 1A subfamilies. Berson A; Wolf C; Chachaty C; Fisch C; Fau D; Eugene D; Loeper J; Gauthier JC; Beaune P; Pompon D J Pharmacol Exp Ther; 1993 Apr; 265(1):366-72. PubMed ID: 8386241 [TBL] [Abstract][Full Text] [Related]
19. Monooxygenase-mediated activation of chlorotrianisene (TACE) in covalent binding to rat hepatic microsomal proteins. Juedes MJ; Bulger WH; Kupfer D Drug Metab Dispos; 1987; 15(6):786-93. PubMed ID: 2893703 [TBL] [Abstract][Full Text] [Related]
20. Cytochrome P-450 isoenzyme content and monooxygenase activities in rat liver: effect of ontogenesis and pretreatment by phenobarbital and 3-methylcholanthrene. Cresteil T; Beaune P; Celier C; Leroux JP; Guengerich FP J Pharmacol Exp Ther; 1986 Jan; 236(1):269-76. PubMed ID: 3941398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]